RU2008116176A - Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукта питания или напитки, ингибирующие постпрандиальную гипергликемию - Google Patents

Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукта питания или напитки, ингибирующие постпрандиальную гипергликемию Download PDF

Info

Publication number
RU2008116176A
RU2008116176A RU2008116176/15A RU2008116176A RU2008116176A RU 2008116176 A RU2008116176 A RU 2008116176A RU 2008116176/15 A RU2008116176/15 A RU 2008116176/15A RU 2008116176 A RU2008116176 A RU 2008116176A RU 2008116176 A RU2008116176 A RU 2008116176A
Authority
RU
Russia
Prior art keywords
glucagon
peptide
secretion
inhibitor
postprandial
Prior art date
Application number
RU2008116176/15A
Other languages
English (en)
Other versions
RU2388485C2 (ru
Inventor
Йоусуке ИТОХ (JP)
Йоусуке ИТОХ
Коудзи НОМАГУТИ (JP)
Коудзи НОМАГУТИ
Мунео ЯМАДА (JP)
Мунео ЯМАДА
Original Assignee
Моринага Милк Индастри Ко., Лтд. (Jp)
Моринага Милк Индастри Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Моринага Милк Индастри Ко., Лтд. (Jp), Моринага Милк Индастри Ко., Лтд. filed Critical Моринага Милк Индастри Ко., Лтд. (Jp)
Publication of RU2008116176A publication Critical patent/RU2008116176A/ru
Application granted granted Critical
Publication of RU2388485C2 publication Critical patent/RU2388485C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202Casein or caseinates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1. Лекарственный стимулятор секреции глюкагон-подобного пептида 1, содержащий κ-казеин в качестве активного ингредиента. ! 2. Лекарственный ингибитор постпрандиальной гипергликемии, содержащий κ-казеин в качестве активного ингредиента.

Claims (2)

1. Лекарственный стимулятор секреции глюкагон-подобного пептида 1, содержащий κ-казеин в качестве активного ингредиента.
2. Лекарственный ингибитор постпрандиальной гипергликемии, содержащий κ-казеин в качестве активного ингредиента.
RU2008116176/15A 2005-09-30 2006-09-29 Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукты питания или напитки, ингибирующие постпрандиальную гипергликемию RU2388485C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005-288338 2005-09-30
JP2005288338 2005-09-30

Publications (2)

Publication Number Publication Date
RU2008116176A true RU2008116176A (ru) 2009-10-27
RU2388485C2 RU2388485C2 (ru) 2010-05-10

Family

ID=37899833

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008116176/15A RU2388485C2 (ru) 2005-09-30 2006-09-29 Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукты питания или напитки, ингибирующие постпрандиальную гипергликемию

Country Status (11)

Country Link
US (3) US20090131316A1 (ru)
EP (1) EP1941899A4 (ru)
JP (1) JP4180645B2 (ru)
KR (1) KR100996985B1 (ru)
CN (1) CN101272803B (ru)
AU (1) AU2006295785B2 (ru)
CA (1) CA2624123C (ru)
HK (1) HK1120440A1 (ru)
NZ (1) NZ567046A (ru)
RU (1) RU2388485C2 (ru)
WO (1) WO2007037413A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101771867B1 (ko) 2013-06-12 2017-08-25 마루하 니치로 가부시키가이샤 디펩티딜 펩티다아제 ⅳ (dppⅳ) 저해 펩티드 화합물, 그것을 함유하는 조성물, 및 그 제조 방법
JP2017165661A (ja) * 2016-03-14 2017-09-21 雪印メグミルク株式会社 糖質代謝改善剤
AU2018227125A1 (en) * 2017-03-03 2019-10-24 Morinaga Milk Industry Co., Ltd. GLP-1 secretagogue and composition
KR101969719B1 (ko) 2017-07-04 2019-04-17 한남대학교 산학협력단 리시닐-프럭토오즈(Lysinyl-Fructose, LF)를 포함하는 혈당상승 억제제 및 그 제조방법
KR102043461B1 (ko) 2017-12-21 2019-11-11 주식회사 프로테인웍스 아스코르빈산 및 니아신을 포함하는 식후 혈당상승억제용 조성물
JP7146676B2 (ja) * 2019-03-15 2022-10-04 日清食品ホールディングス株式会社 分泌促進能評価試験方法
JP7450612B2 (ja) * 2019-04-26 2024-03-15 サントリーホールディングス株式会社 Glp-1分泌促進用組成物
EP3916006A1 (en) 2020-05-26 2021-12-01 Consejo Superior de Investigaciones Científicas (CSIC) Peptides capable of inducing anorexic hormones, compositions and uses thereof
KR20230057134A (ko) 2021-10-21 2023-04-28 한가람비앤에프 주식회사 해죽순 추출물을 포함하는 식후 혈당상승억제용 조성물
KR102450000B1 (ko) 2022-02-20 2022-09-30 이용호 커피 추출물을 포함하는 식후 혈당상승억제용 조성물
KR20230174959A (ko) 2022-06-22 2023-12-29 농업회사법인 그린생명주식회사 아마도리 화합물을 고농도로 함유하는 홍삼 추출물을 포함하는 식후 혈당상승억제용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
JP2673320B2 (ja) * 1990-01-25 1997-11-05 雪印乳業株式会社 う蝕原菌付着阻止剤
WO1996008269A1 (en) 1994-09-16 1996-03-21 Abbott Laboratories Inhibition of human rotavirus infection
NZ333652A (en) 1994-09-16 2000-07-28 Abbott Lab Inhibition of human rotavirus infection using kappa-casein
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
GB0116509D0 (en) * 2001-07-06 2001-08-29 Hannah Res Inst The Methods of extracting casein fractions from milk and caseinates and production of novel products
DE60227922D1 (de) * 2002-05-27 2008-09-11 Nestec Sa Säurelösliche Proteine aus Casein-Micellen
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
JPWO2004050118A1 (ja) * 2002-11-29 2006-03-30 森永乳業株式会社 プロテアーゼ阻害剤
AU2003270130A1 (en) * 2003-08-30 2005-03-16 Nestec S.A. Acid soluble proteins from micellar casein

Also Published As

Publication number Publication date
EP1941899A4 (en) 2009-11-11
CN101272803A (zh) 2008-09-24
EP1941899A1 (en) 2008-07-09
RU2388485C2 (ru) 2010-05-10
CN101272803B (zh) 2012-11-21
JP4180645B2 (ja) 2008-11-12
KR20080043867A (ko) 2008-05-19
AU2006295785A1 (en) 2007-04-05
US8114837B2 (en) 2012-02-14
WO2007037413A1 (ja) 2007-04-05
US20120108508A1 (en) 2012-05-03
JPWO2007037413A1 (ja) 2009-04-16
NZ567046A (en) 2010-11-26
CA2624123C (en) 2011-11-15
HK1120440A1 (en) 2009-04-03
US20090131316A1 (en) 2009-05-21
AU2006295785B2 (en) 2009-10-29
KR100996985B1 (ko) 2010-11-26
CA2624123A1 (en) 2007-04-05
US20100144638A1 (en) 2010-06-10
US8367608B2 (en) 2013-02-05

Similar Documents

Publication Publication Date Title
RU2008116176A (ru) Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукта питания или напитки, ингибирующие постпрандиальную гипергликемию
MX2020008271A (es) Inhibidor de fap.
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
DE60327103D1 (de) Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer
TW200505881A (en) Tri(cyclo) substituted amide compounds
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
UA94221C2 (en) Lipocalin protein
HK1121074A1 (en) Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione
WO2006097536A3 (en) Dimeric peptide agonists of the glp-1 receptor
EP2331072A4 (en) METHODS AND COMPOSITIONS FOR ORAL PROTEIN DELIVERY
EA201170149A1 (ru) Новые аналоги инсулина пролонгированной активности
WO2006114805A3 (en) Use of hmgb2 and hmgb3 proteins for medical applications
MX2008001597A (es) Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento.
AU2003207417A1 (en) Use of tryptophan rich peptides
PL1622939T3 (pl) Aktywne warianty białka wiążącego IL-18 i ich medyczne zastosowania
MY140538A (en) Substituted n-acyl-2-aminothiazoles
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
EP1632241A4 (en) MEANS FOR THE PREVENTION AND / OR HEALING OF DISEASES IN CONNECTION WITH TISSUE DISORDER
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
ATE485831T1 (de) Behandlung von neurodegeneration
MX2022003096A (es) Tratamiento de la diabetes mellitus tipo 2.
DE112006002041A5 (de) Pharmazeutisch wirksame Zusammensetzung zur Behandlung von Diabetes
DE602004030265D1 (de) Behandlung von gastrointestinalen stromatumoren mit imatinib und midostaurin
UA90843C2 (ru) Соединения три(цикло)-замещенных амидов